207 related articles for article (PubMed ID: 18053727)
21. Binding mode analyses and pharmacophore model development for sulfonamide chalcone derivatives, a new class of alpha-glucosidase inhibitors.
Bharatham K; Bharatham N; Park KH; Lee KW
J Mol Graph Model; 2008 Jun; 26(8):1202-12. PubMed ID: 18096420
[TBL] [Abstract][Full Text] [Related]
22. A novel range based QSAR study of human neuropeptide Y (NPY) Y5 receptor inhibitors.
Deswal S; Roy N
Eur J Med Chem; 2007 Apr; 42(4):463-70. PubMed ID: 17083999
[TBL] [Abstract][Full Text] [Related]
23. Novel ligands for the chemokine receptor-3 (CCR3): a receptor-modeling study based on 5D-QSAR.
Vedani A; Dobler M; Dollinger H; Hasselbach KM; Birke F; Lill MA
J Med Chem; 2005 Mar; 48(5):1515-27. PubMed ID: 15743194
[TBL] [Abstract][Full Text] [Related]
24. Prediction of anti-HIV-1 activity of a series of tetrapyrrole molecules.
Vanyúr R; Héberger K; Jakus J
J Chem Inf Comput Sci; 2003; 43(6):1829-36. PubMed ID: 14632429
[TBL] [Abstract][Full Text] [Related]
25. GRID formalism for the comparative molecular surface analysis: application to the CoMFA benchmark steroids, azo dyes, and HEPT derivatives.
Polanski J; Gieleciak R; Magdziarz T; Bak A
J Chem Inf Comput Sci; 2004; 44(4):1423-35. PubMed ID: 15272850
[TBL] [Abstract][Full Text] [Related]
26. Predicting anti-HIV-1 activity of 6-arylbenzonitriles: computational approach using superaugmented eccentric connectivity topochemical indices.
Dureja H; Gupta S; Madan AK
J Mol Graph Model; 2008 Feb; 26(6):1020-9. PubMed ID: 17919954
[TBL] [Abstract][Full Text] [Related]
27. A ligand-based approach for the in silico discovery of multi-target inhibitors for proteins associated with HIV infection.
Speck-Planche A; Kleandrova VV; Luan F; Cordeiro MN
Mol Biosyst; 2012 Aug; 8(8):2188-96. PubMed ID: 22688327
[TBL] [Abstract][Full Text] [Related]
28. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
[TBL] [Abstract][Full Text] [Related]
29. QSAR models for 2-amino-6-arylsulfonylbenzonitriles and congeners HIV-1 reverse transcriptase inhibitors based on linear and nonlinear regression methods.
Hu R; Doucet JP; Delamar M; Zhang R
Eur J Med Chem; 2009 May; 44(5):2158-71. PubMed ID: 19054595
[TBL] [Abstract][Full Text] [Related]
30. Design, molecular modeling, synthesis, and anti-HIV-1 activity of new indolyl aryl sulfones. Novel derivatives of the indole-2-carboxamide.
Ragno R; Coluccia A; La Regina G; De Martino G; Piscitelli F; Lavecchia A; Novellino E; Bergamini A; Ciaprini C; Sinistro A; Maga G; Crespan E; Artico M; Silvestri R
J Med Chem; 2006 Jun; 49(11):3172-84. PubMed ID: 16722636
[TBL] [Abstract][Full Text] [Related]
31. Rational optimization of the binding affinity of CD4 targeting peptidomimetics with potential anti HIV activity.
Neffe AT; Bilang M; Grüneberg I; Meyer B
J Med Chem; 2007 Jul; 50(15):3482-8. PubMed ID: 17602545
[TBL] [Abstract][Full Text] [Related]
32. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
Li Z; Han J; Chen HF
Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
[TBL] [Abstract][Full Text] [Related]
33. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
34. Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.
Teixeira C; Barbault F; Rebehmed J; Liu K; Xie L; Lu H; Jiang S; Fan B; Maurel F
Bioorg Med Chem; 2008 Mar; 16(6):3039-48. PubMed ID: 18226912
[TBL] [Abstract][Full Text] [Related]
35. Discovery of novel HIV entry inhibitors for the CXCR4 receptor by prospective virtual screening.
Pérez-Nueno VI; Pettersson S; Ritchie DW; Borrell JI; Teixidó J
J Chem Inf Model; 2009 Apr; 49(4):810-23. PubMed ID: 19358515
[TBL] [Abstract][Full Text] [Related]
36. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
[TBL] [Abstract][Full Text] [Related]
37. Multitemplate alignment method for the development of a reliable 3D-QSAR model for the analysis of MMP3 inhibitors.
Tuccinardi T; Ortore G; Santos MA; Marques SM; Nuti E; Rossello A; Martinelli A
J Chem Inf Model; 2009 Jul; 49(7):1715-24. PubMed ID: 19522467
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of a neural networks QSAR method based on ligand representation using substituent descriptors. Application to HIV-1 protease inhibitors.
Milac AL; Avram S; Petrescu AJ
J Mol Graph Model; 2006 Sep; 25(1):37-45. PubMed ID: 16325439
[TBL] [Abstract][Full Text] [Related]
39. Structural analysis of carboline derivatives as inhibitors of MAPKAP K2 using 3D QSAR and docking studies.
Nayana RS; Bommisetty SK; Singh K; Bairy SK; Nunna S; Pramod A; Muttineni R
J Chem Inf Model; 2009 Jan; 49(1):53-67. PubMed ID: 19119997
[TBL] [Abstract][Full Text] [Related]
40. Lysine sulfonamides as novel HIV-protease inhibitors: Nepsilon-acyl aromatic alpha-amino acids.
Stranix BR; Lavallée JF; Sévigny G; Yelle J; Perron V; LeBerre N; Herbart D; Wu JJ
Bioorg Med Chem Lett; 2006 Jul; 16(13):3459-62. PubMed ID: 16644213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
